COVID-NMA is an international research initiative led by the Centre for Research in Epidemiology and Statistics (CRESS) and Cochrane France, and the World Health Organization (WHO).[1][2]
Organization
COVID-NMA is an organizational partner of the COVID-19 Evidence Network to Support Decision-making (COVID-END).[3]
Funding
COVID-NMA is funded by:[1:1]
- Agence Nationale de la Recherche (ANR)
- Assistance Publique Hopitaux de Paris
- Centre for Evidence-Based Medicine Odense (CEBMO)
- Centre national de la recherche scientifique (CNRS)
- Centre for Research in Epidemiology and Statistics (CRESS)
- Cochrane Chile
- Cochrane Denmark
- Cochrane France
- Cochrane Germany
- Cochrane Ireland
- Cochrane South Africa
- Epistemonikos Foundation
- Evidence Synthesis Ireland
- Fondazione IRCCS Ca' Ospedale Maggiore Policlinico
- French Ministry of Health and Access to Care
- French Ministry of Higher Education and Research (MHER)
- French National Centre for Scientific Research (CNRS)
- German Federal Ministry of Education and Research (BMBF)
- Institut national de la santé et de la recherche médicale (Inserm)
- Università Degli Studi di Milano
- Université Paris Cité
- University Medical Center Freiburg
- VACCELERATE
External links
Home. COVID-NMA. Retrieved March 13, 2023, from https://web.archive.org/web/20230313124525/https://www.covid-nma.com/ ↩︎ ↩︎
Who We Are. COVID-NMA. Retrieved April 8, 2025, from https://web.archive.org/web/20250408072106/https://covid-nma.com/about-us/who-we-are.php ↩︎
COVID-END - Partners. McMaster Health Forum. Retrieved August 9, 2024, from https://web.archive.org/web/20240809000745/https://www.mcmasterforum.org/networks/covid-end/archive-for-covid-end-global/about-covid-end/partners ↩︎
